MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice

被引:285
作者
Zhang, Zheng [1 ,2 ]
Peng, Huimin [1 ,2 ]
Chen, Junxia [1 ,2 ]
Chen, Xin [3 ]
Han, Fei [1 ]
Xu, Xiaoming [1 ]
He, Xiaoyan [1 ]
Yan, Ning [1 ]
机构
[1] Chongqing Med Univ, Dept Cell Biol & Med Genet, Chongqing, Peoples R China
[2] Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
Diabetic nephropathy; Mesangial cell; MicroRNAs; PTEN phosphohydrolase; SUPPRESSOR GENE; EXPRESSION; PTEN; IDENTIFICATION; HYPERTROPHY; DISEASE; TARGETS; CANCER; MOUSE; SIZE;
D O I
10.1016/j.febslet.2009.05.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Diabetic nephropathy (DN) is a major diabetic complication. But the initiating molecular events triggering DN are unknown. Recent researches have addressed the role of microRNAs in diabetes and its complications. In this study, we looked for microRNAs expression during early DN, and showed microRNA-21 (miR-21) expression was downregulated in response to early DN in vitro and in vivo. Over-expression of miR-21 inhibited proliferation of mesangial cells and decreased the 24-h urine albumin excretion rate in diabetic db/db mice. Moreover, we identified PTEN as a target of miR-21. We also found PI3 K and p-Akt increased in miR-21 treated mesangial cells and db/db mice. Overall, these studies for the first time provide evidence for the potential role of miR-21 in early DN. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:2009 / 2014
页数:6
相关论文
共 23 条
[1]
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease [J].
Backman, SA ;
Stambolic, V ;
Suzuki, A ;
Haight, J ;
Elia, A ;
Pretorius, J ;
Tsao, MS ;
Shannon, P ;
Bolon, B ;
Ivy, GO ;
Mak, TW .
NATURE GENETICS, 2001, 29 (04) :396-403
[2]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]
The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[4]
Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways [J].
Crackower, MA ;
Oudit, GY ;
Kozieradzki, I ;
Sarao, R ;
Sun, H ;
Sasaki, T ;
Hirsch, E ;
Suzuki, A ;
Shioi, T ;
Irie-Sasaki, J ;
Sah, R ;
Cheng, HYM ;
Rybin, VO ;
Lembo, G ;
Fratta, L ;
Oliveira-dos-Santos, AJ ;
Benovic, JL ;
Kahn, CR ;
Izumo, S ;
Steinberg, SF ;
Wymann, MP ;
Backx, PH ;
Penninger, JM .
CELL, 2002, 110 (06) :737-749
[5]
MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer [J].
Dahiya, Neetu ;
Sherman-Baust, Cheryl A. ;
Wang, Tian-Li ;
Davidson, Ben ;
Shih, Ie-Ming ;
Zhang, Yongqing ;
Wood, William, III ;
Becker, Kevin G. ;
Morin, Patrice J. .
PLOS ONE, 2008, 3 (06)
[6]
Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes [J].
He, Aibin ;
Zhu, Liuluan ;
Gupta, Nishith ;
Chang, Yongsheng ;
Fang, Fude .
MOLECULAR ENDOCRINOLOGY, 2007, 21 (11) :2785-2794
[7]
Jiang GQ, 2002, FRONT BIOSCI-LANDMRK, V7, pD904
[8]
Human MicroRNA targets [J].
John, B ;
Enright, AJ ;
Aravin, A ;
Tuschl, T ;
Sander, C ;
Marks, DS .
PLOS BIOLOGY, 2004, 2 (11) :1862-1879
[9]
Combinatorial microRNA target predictions [J].
Krek, A ;
Grun, D ;
Poy, MN ;
Wolf, R ;
Rosenberg, L ;
Epstein, EJ ;
MacMenamin, P ;
da Piedade, I ;
Gunsalus, KC ;
Stoffel, M ;
Rajewsky, N .
NATURE GENETICS, 2005, 37 (05) :495-500
[10]
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations [J].
Ladeiro, Yannick ;
Couchy, Gabrielle ;
Balabaud, Charles ;
Bioulac-Sage, Paulette ;
Pelletier, Laura ;
Rebouissou, Sandra ;
Zucman-Rossi, Jessica .
HEPATOLOGY, 2008, 47 (06) :1955-1963